Skip to content

FDA cautions that Kaletra should not be used by patients with heart rhythm problems or underlying heart conditions

Task-shifting key to achieving South Africa's treatment goal

Second-line therapy

When to start treatment: leave it no later than 350, major studies agree

Study shows potential for using dried blood spots for HIV viral load testing

Vitamin D supplementation may help with tenofovir-related bone hormone deficiency

London patient surveys find widely different rates of patients referred to care and lost to follow-up

HIV treatment is not the cause of cryptogenic liver disease

Peripheral neuropathy in people with HIV in resource-limited settings

Peripheral neuropathy in people with HIV in resource-limited settings